Open Targets Platform How Open Targets is using Artificial Intelligence and Machine Learning to identify and prioritise drug targets 2 years ago • 5 min read
Experimental Science How Lorenzo Bomba is using rare genetic variants to understand blood metabolites 3 years ago • 5 min read
Open Targets Platform How we overhauled our literature processing pipeline using Named Entity Recognition 3 years ago • 7 min read
Life at Open Targets How Nuria Lopez-Bigas is untangling the genetics of cancer 3 years ago • 6 min read
Life at Open Targets Untangling the genetics of neuroinflammation: an interview with Yixi Chen 3 years ago • 5 min read
Life at Open Targets From genomes to medicines: an interview with Ian Dunham 3 years ago • 10 min read
Experimental Science Off the beaten path: combining genetic and small molecule approaches to validate novel drug targets 3 years ago • 6 min read
Experimental Science The PROTACtable genome: a systematic assessment of drug target tractability 3 years ago • 2 min read
Release Notes The next-generation Open Targets Platform: rebuilt, redesigned, reimagined 4 years ago • 7 min read
